Alenezi Haitham, Lampmann Tim, Asoglu Harun, Jaber Mohammed, Banat Mohammed, Vatter Hartmut, Eichhorn Lars, Hamed Motaz
Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.
Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Helios Hospital Bonn/Rhein-Sieg, Bonn, Germany.
Eur J Trauma Emerg Surg. 2025 Jul 21;51(1):263. doi: 10.1007/s00068-025-02939-y.
Chronic subdural hematoma (CSDH) is a common neurosurgical condition, especially in the elderly, which is usually diagnosed by computed tomography (CT) scan and often treated surgically. After surgery patients shows favourable outcomes with improvement in symptomatology. Despite the availability of various surgical techniques, complications continue to occur frequently due to the advanced age of patients and underlying medical conditions. Burr-hole craniotomy followed by placement a closed-system drainage is widely considered the best treatment for CSDH, although technical challenges and a high recurrence rate remain. Postoperative pneumocephalus is a potential risk factor for recurrence. While the majority of patients recover well after surgery, recurrence or persistence of CSDH occurs in 0.35-33% of cases, sometimes necessitating additional surgeries.
This retrospective study comprehensively evaluates the clinical data of 229 patients diagnosed with chronic subdural hematoma (CSDH) who underwent surgical intervention, specifically burr-hole craniotomy with drainage between 2016 and 2021. The primary objective is to measure the prognostic significance of postoperative pneumocephalus as a predictor of recurrence of CSDH. Furthermore, the obtained univariate and multivariate regression analyses examines various patient-specific factors, including age, gender, location of CSDH (unilateral or bilateral), anticoagulation therapy status, neurosurgical follow-up outcomes, hospital readmission rates, and the incidence of repeat surgical procedures.
Among the analysed characteristics, postoperative pneumocephalus exceeding a specified volumetric threshold emerges as the only significant predictor of CSDH recurrence. This recurrence of CSDH is additionally associated with a substantial prolongation of the patient's hospitalization, highlighting its clinical and logistical significance.
A postoperative pneumocephalus is nearly unavoidable; however, optimizing surgical technique to minimize its volume below 5.2 cm reduces significantly the recurrence rate of CSDH.
慢性硬膜下血肿(CSDH)是一种常见的神经外科疾病,在老年人中尤为常见,通常通过计算机断层扫描(CT)诊断,且常需手术治疗。术后患者症状改善,预后良好。尽管有多种手术技术,但由于患者年龄较大及基础疾病,并发症仍频繁发生。钻孔开颅术并放置闭式引流被广泛认为是治疗CSDH的最佳方法,尽管仍存在技术挑战和高复发率。术后气颅是复发的潜在危险因素。虽然大多数患者术后恢复良好,但CSDH复发或持续存在的病例占0.35%-33%,有时需要再次手术。
本回顾性研究全面评估了2016年至2021年间229例诊断为慢性硬膜下血肿(CSDH)并接受手术干预(具体为钻孔开颅引流)患者的临床资料。主要目的是衡量术后气颅作为CSDH复发预测指标的预后意义。此外,通过单因素和多因素回归分析研究各种患者特异性因素,包括年龄、性别、CSDH位置(单侧或双侧)、抗凝治疗状态、神经外科随访结果、医院再入院率以及再次手术的发生率。
在分析的特征中,超过特定体积阈值的术后气颅是CSDH复发的唯一显著预测指标。CSDH的这种复发还与患者住院时间的大幅延长相关,凸显了其临床和后勤意义。
术后气颅几乎不可避免;然而,优化手术技术将其体积降至5.2 cm以下可显著降低CSDH的复发率。